Cingulate Revenue vs. Return On Equity

CING Stock  USD 4.34  0.14  3.33%   
Based on the measurements of profitability obtained from Cingulate's financial statements, Cingulate may not be well positioned to generate adequate gross income at this time. It has a very high odds of underperforming in February. Profitability indicators assess Cingulate's ability to earn profits and add value for shareholders.
 
Total Revenue  
First Reported
2020-09-30
Previous Quarter
0.0
Current Value
0.0
Quarterly Volatility
3.2 B
 
Covid
At this time, Cingulate's Days Payables Outstanding is most likely to decrease significantly in the upcoming years. The Cingulate's current Net Debt To EBITDA is estimated to increase to 0.45, while Free Cash Flow Yield is forecasted to increase to (1.08). The current Gross Profit is estimated to decrease to about (617.2 K)
For Cingulate profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Cingulate to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Cingulate utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Cingulate's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Cingulate over time as well as its relative position and ranking within its peers.
Check out Trending Equities.
For more detail on how to invest in Cingulate Stock please use our How to Invest in Cingulate guide.The next projected EPS of Cingulate is estimated to be -2.95625 with future projections ranging from a low of -8.82 to a high of -0.9125. Cingulate's most recent 12-month trailing earnings per share (EPS TTM) is at -2.77. Please be aware that the consensus of earnings estimates for Cingulate is based on EPS before non-recurring items and includes expenses related to employee stock options.
 
Covid
Cingulate is projected to generate -2.95625 in earnings per share on the 31st of December 2025. Cingulate earnings estimates show analyst consensus about projected Cingulate EPS (Earning Per Share). It derives the highest and the lowest estimates based on Cingulate's historical volatility. Many public companies, such as Cingulate, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm. By analyzing Cingulate's earnings estimates, investors can diagnose different trends across Cingulate's analyst sentiment over time as well as compare current estimates against different timeframes.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cingulate. If investors know Cingulate will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cingulate listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.77)
Return On Assets
(1.07)
Return On Equity
(2.76)
The market value of Cingulate is measured differently than its book value, which is the value of Cingulate that is recorded on the company's balance sheet. Investors also form their own opinion of Cingulate's value that differs from its market value or its book value, called intrinsic value, which is Cingulate's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cingulate's market value can be influenced by many factors that don't directly affect Cingulate's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cingulate's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cingulate is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cingulate's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Cingulate Return On Equity vs. Revenue Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Cingulate's current stock value. Our valuation model uses many indicators to compare Cingulate value to that of its competitors to determine the firm's financial worth.
Cingulate is currently under evaluation in revenue category among its peers. It is rated below average in return on equity category among its peers . At this time, Cingulate's Total Revenue is most likely to stay steady in the upcoming years. Comparative valuation analysis is a catch-all technique that is used if you cannot value Cingulate by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Cingulate Revenue vs. Competition

Cingulate is currently under evaluation in revenue category among its peers. Market size based on revenue of Health Care industry is currently estimated at about 29.25 Million. Cingulate adds roughly 0.0 in revenue claiming only tiny portion of equities under Health Care industry.

Cingulate Return On Equity vs. Revenue

Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.

Cingulate

Revenue

 = 

Money Received

-

Discounts and Returns

 = 
null
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

Cingulate

Return On Equity

 = 

Net Income

Total Equity

 = 
-2.76
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.

Cingulate Return On Equity Comparison

Cingulate is currently under evaluation in return on equity category among its peers.

Cingulate Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Cingulate, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Cingulate will eventually generate negative long term returns. The profitability progress is the general direction of Cingulate's change in net profit over the period of time. It can combine multiple indicators of Cingulate, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Accumulated Other Comprehensive Income 189.75  132.74 
Net Interest Income89.3 K93.8 K
Operating Income-14.1 M-14.8 M
Net Loss-14 M-14.7 M
Income Before Tax-14 M-14.7 M
Total Other Income Expense Net89.3 K93.8 K
Net Loss-15.9 M-16.7 M
Net Loss-14 M-14.7 M
Income Tax Expense(302.45)(287.33)
Change To Netincome920.9 K874.9 K
Net Loss(3.67)(3.85)
Income Quality 1.07  1.01 
Net Income Per E B T 0.90  0.80 

Cingulate Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Cingulate. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Cingulate position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Cingulate's important profitability drivers and their relationship over time.

Cingulate Earnings Estimation Breakdown

The calculation of Cingulate's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Cingulate is estimated to be -2.95625 with the future projection ranging from a low of -8.82 to a high of -0.9125. Please be aware that this consensus of annual earnings estimates for Cingulate is based on EPS before non-recurring items and includes expenses related to employee stock options.
Last Reported EPS
-1.35
-8.82
Lowest
Expected EPS
-2.95625
-0.91
Highest

Cingulate Earnings Projection Consensus

Suppose the current estimates of Cingulate's value are higher than the current market price of the Cingulate stock. In this case, investors may conclude that Cingulate is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Cingulate's stock will quickly adjusts to the new information provided by the consensus estimate.
Number of AnalystsHistorical AccuracyLast Reported EPSEstimated EPS for 31st of December 2025Current EPS (TTM)
472.34%
-1.35
-2.95625
-2.77

Cingulate Earnings per Share Projection vs Actual

Actual Earning per Share of Cingulate refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Cingulate predict the company's earnings will be in the future. The higher the earnings per share of Cingulate, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.

Cingulate Estimated Months Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as Cingulate, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Cingulate should always be considered in relation to other companies to make a more educated investment decision.

Cingulate Quarterly Analyst Estimates and Surprise Metrics

Earnings surprises can significantly impact Cingulate's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2025-11-13
2025-09-30-0.95-1.35-0.442 
2025-08-19
2025-06-30-0.93-2.14-1.21130 
2025-05-08
2025-03-31-0.94-1.04-0.110 
2025-03-27
2024-12-31-2.93-3.68-0.7525 
2024-11-11
2024-09-30-2.22-1.830.3917 
2024-08-13
2024-06-30-4.92-5.47-0.5511 
2024-05-08
2024-03-31-12.48-7.25.2842 
2024-03-31
2023-12-31-4.86-7.66-2.857 
2023-11-13
2023-09-30-0.37-0.30.0718 
2023-08-14
2023-06-30-0.35-0.57-0.2262 
2023-05-10
2023-03-31-0.34-0.35-0.01
2023-03-10
2022-12-31-0.37-0.41-0.0410 
2022-11-14
2022-09-30-0.37-0.360.01
2022-08-11
2022-06-30-0.58-0.360.2237 
2022-05-12
2022-03-31-0.23-0.44-0.2191 
2022-03-10
2021-12-31-0.39-0.320.0717 
2021-12-09
2021-09-300-1.38-1.38
2021-09-27
2021-06-300-0.35-0.35

Use Cingulate in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cingulate position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cingulate will appreciate offsetting losses from the drop in the long position's value.

Cingulate Pair Trading

Cingulate Pair Trading Analysis

The ability to find closely correlated positions to Cingulate could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cingulate when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cingulate - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cingulate to buy it.
The correlation of Cingulate is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cingulate moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cingulate moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cingulate can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Cingulate position

In addition to having Cingulate in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Exotic Funds Thematic Idea Now

Exotic Funds
Exotic Funds Theme
Funds or Etfs with high minimum investment requirement that manage portfolios of alternative investments such as hedge funds, options, futures, real estate or commodities. The Exotic Funds theme has 43 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Exotic Funds Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Cingulate is a strong investment it is important to analyze Cingulate's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Cingulate's future performance. For an informed investment choice regarding Cingulate Stock, refer to the following important reports:
Check out Trending Equities.
For more detail on how to invest in Cingulate Stock please use our How to Invest in Cingulate guide.
You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
To fully project Cingulate's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Cingulate at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Cingulate's income statement, its balance sheet, and the statement of cash flows.
Potential Cingulate investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Cingulate investors may work on each financial statement separately, they are all related. The changes in Cingulate's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Cingulate's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.